Neuland Laboratories Ltd. | Mutual Funds
Mutual Funds that own Neuland Laboratories Ltd.
SBI Pharma Fund
260,000
2.93%
10,000
1.85%
06/30/2018
Nomura Asset India Equity Mother Fund
195,971
2.21%
51,005
0.21%
09/12/2017
L&T India Value Fund
148,058
1.67%
-4,911
0.14%
07/31/2018
India Capital Growth Fund
148,000
1.67%
19,004
0.95%
06/30/2017
DFA Emerging Markets Core Equity Portfolio
17,291
0.2%
0
0%
04/30/2018
DFA Emerging Markets Small Cap Series
12,517
0.14%
556
0%
01/31/2018
DFA Emerging Markets Social Core Equity Portfolio
1,555
0.02%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
686
0.01%
0
0%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
504
0.01%
0
0%
04/30/2018
SBI State Bank of India Indian Equity Mother Fund
0
0%
-23,960
0%
12/05/2016
| Address |
Sanali Info Park, A Block
Hyderabad TS 500034
India
|
|
Employees
|
- |
| Website |
http://www.neulandlabs.com |
| Updated |
09/14/2018 |
| Neuland Laboratories Ltd. is holding company, which engages in the research, development, and commercialization of active pharmaceutical ingredients and intermediates for the generics industry. It offers custom manufacturing solutions and synthetic peptides. The company was founded by Rama Mohan Rao Davuluri on January 7, 1984 and is headquartered in Hyderabad, India. |
